吡啶甲酸铬 T4575

Product Introduction
Bioactivity


英文名: Chromium picolinate

描述: Chromium picolinate 具有降低胰岛素抵抗的作用，对 2 型糖尿病具有潜在的研究价值。

体内活性: Acrivastine (usually 8mg three times daily) is an effective and well-tolerated antihistamine in the treatment of chronic urticaria and allergic rhinitis. Acrivastine causes less drowsiness than clemastine, the incidence of adverse effects being indistinguishable from that with placebo or terfenadine. In the treatment of dermatoses in which histamine has a pathogenetic role, the efficacy of acrivastine is superior to that of placebo and similar to that of usual dosages of clemastine, hydroxyzine, chlorpheniramine, cyproheptadine or terfenadine [1]. Both 4 mg and 8 mg acrivastine alleviate the symptoms of seasonal allergic rhinitis with significant improvements in the symptom scores for sneezing, running nose and the calculated overall score. In addition, 8 mg acrivastine reduces the symptom scores for watery eyes and itchy throat. Acrivastine is both well tolerated and effective in the treatment of seasonal allergic rhinitis [2].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 4.18 mg/mL (10 mM)


关键字: Inhibitor | Chromium picolinate | inhibit | Chromium (III) picolinate | Cr(Pic)3

相关产品: L82 | Tallimustine HCl | Norharmane | Dibenz[a,h]anthracene | Proflavine Hemisulfate | Quinacrine dihydrochloride | Pterine-6-carboxylic acid | RU.521 | 3,7,4'-Trihydroxyflavone | Hydroxychloroquine sulfate

相关库: Drug Repurposing Compound Library | FDA-Approved Kinase Inhibitor Library | Anti-Cancer Drug Library | Cancer Cell Differentiation Compound Library | Anti-Cancer Clinical Compound Library | Kinase Inhibitor Library | Anti-Colorectal Cancer Compound Library | Anti-Cancer Approved Drug Library | Anti-Pancreatic Cancer Compound Library | Reprogramming Compound Library

吡啶甲酸铬 T4575信息由TargetMol中国为您提供，如您想了解更多关于吡啶甲酸铬 T4575报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途